NSC |
Compound |
Enrichment |
Correlation |
NSC 703315 |
Null |
0.0304779558345019 |
0.26180012 |
NSC 709100 |
Null |
0.0304779558345019 |
0.32793104 |
NSC 720765 |
Methyl (E)-O-methyloxyimino-2-[2-(trifluoromethyl)phenoxymethyl]phe nylacetate |
0.0304779558345019 |
0.18468097 |
NSC 732517 |
Dasatinib |
0.0304779558345019 |
0.056733248 |
NSC 733164 |
Null |
0.0304779558345019 |
0.065711857 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.0304779558345019 |
0.4066049 |
NSC 736153 |
Null |
0.0304779558345019 |
0.21457764 |
NSC 740270 |
6-(10'-tert-BOC-aminodecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0304779558345019 |
0.065446272 |
NSC 742838 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride |
0.0304779558345019 |
0.54155435 |
NSC 744020 |
methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate |
0.0304779558345019 |
0.013194805 |